Neuronetics, Inc. Retained Earnings
Neuronetics, Inc. (STIM) had Retained Earnings of -$473.15 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-11
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$473.15M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$469.58M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$458.79M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$451.63M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$473.15M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | -$469.58M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | -$458.79M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | -$451.63M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | -$442.58M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | -$432.46M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | -$419.79M 10-K · filed 2026-03-17 | |
| 2024-09-30 | -$263.66M 8-K/A · filed 2025-02-06 | -$407.13M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$393.79M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | -$383.95M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | -$376.08M 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$370.70M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | -$361.31M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | -$356.41M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$345.89M 10-K · filed 2024-03-08 | |
| 2022-09-30 | -$337.60M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | -$329.99M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | -$319.57M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$308.73M 10-K · filed 2023-03-07 | |
| 2021-09-30 | -$301.10M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$292.95M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | -$285.42M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | -$277.54M 10-K · filed 2022-03-08 | |
| 2020-09-30 | -$273.88M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | -$270.46M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | -$262.70M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | -$250.09M 10-K · filed 2021-03-02 | |
| 2019-09-30 | -$242.53M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | -$235.67M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | -$228.57M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | -$221.04M 10-K · filed 2020-03-03 | |
| 2018-09-30 | -$214.90M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | -$209.94M 10-Q · filed 2018-08-14 | |
| 2017-12-31 | -$196.95M 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |